Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-08-19 4:30 pm Purchase |
2022-08-12 | 13G | Silence Therapeutics plc SLN |
TCG Crossover Management LLC | 6,314,625 5.900% |
6,314,625 (New Position) |
Filing History |
| 2021-11-29 1:00 pm Purchase |
2021-11-22 | 13G | CymaBay Therapeutics, Inc. CBAY |
TCG Crossover Management LLC | 5,905,400 7.000% |
5,905,400 (New Position) |
Filing History |
| 2021-11-17 3:39 pm Purchase |
2021-11-05 | 13G | Cogent Biosciences, Inc. COGT |
TCG Crossover Management LLC | 2,716,042 6.800% |
706,054 (+35.13%) |
Filing History |
| 2021-09-29 06:02 am Unchanged |
2021-09-23 | 13G | Viridian Therapeutics, Inc. VRDN |
TCG Crossover Management LLC | 1,314,000 8.200% |
0 (Unchanged) |
Filing History |
| 2021-09-29 06:01 am Unchanged |
2021-09-15 | 13G | Tyra Biosciences, Inc. TYRA |
TCG Crossover Management LLC | 937,500 2.200% |
0 (Unchanged) |
Filing History |
| 2021-09-24 1:59 pm Purchase |
2021-09-21 | 13G | Viridian Therapeutics, Inc. VRDN |
TCG Crossover Management LLC | 1,314,000 13.700% |
400,000 (+43.76%) |
Filing History |
| 2021-09-21 12:16 pm Purchase |
2021-09-15 | 13G | Tyra Biosciences, Inc. TYRA |
TCG Crossover Management LLC | 937,500 8.700% |
937,500 (New Position) |
Filing History |
| 2021-09-10 06:03 am Purchase |
2021-09-01 | 13G | Viridian Therapeutics, Inc. VRDN |
TCG Crossover Management LLC | 914,000 9.500% |
914,000 (New Position) |
Filing History |
| 2021-07-08 1:50 pm Purchase |
2021-06-28 | 13G | Cogent Biosciences, Inc. COGT |
TCG Crossover Management LLC | 2,009,988 5.200% |
2,009,988 (New Position) |
Filing History |